Cytomegalovirus infection is a frequent complication after transplantation. This infection
occurs due to transmission from the transplanted organ, due to reactivation of latent …

Increasingly potent immunosuppressive agents have dramatically reduced the incidence of
rejection of transplanted organs while increasing susceptibility to opportunistic infections …

Human cytomegalovirus (HCMV) infection remains a major cause of morbidity in patient
populations. In certain clinical settings, it is the reactivation of the pre‐existing latent infection …

Infection with human cytomegalovirus (CMV) is an important cause of morbidity and mortality
in kidney transplant recipients. CMV disease is diagnosed based on the detection of viral …

Human cytomegalovirus (HCMV) is an important pathogen in transplant patients and in
congenital infection. Previously, we demonstrated that vaccination with a recombinant viral …

Cytomegalovirus (CMV) is a common viral pathogen in the transplant population and is
associated with significant morbidity and mortality. CMV prevention is paramount; however …

Background. The relationship between cytomegalovirus (CMV) infection and mortality
among immunocompetent individuals is uncertain. We aimed to examine whether …

Human cytomegalovirus (HCMV) remains a major cause of viral disease in
immunosuppressed transplant patients. The ability of HCMV to establish lifelong infection in …

Background. The ultimate goal of organ transplantation is the reestablishment of organ
function and the restoration of a solid immunity to prevent the assault of potentially deadly …

ABSTRACT A vaccine to prevent maternal acquisition of human cytomegalovirus (HCMV)
during pregnancy is a primary strategy to reduce the incidence of congenital disease. The …